Indication
Treatment of complex perianal fistula(s) in adult patients with non-active/mildly active luminal Crohn’s disease (CD), when fistula(s) have shown an inadequate response to at least one conventional or biologic therapy.

Medicine details

Medicine name:
darvadstrocel (Alofisel)
SMC ID:
SMC2115
Pharmaceutical company
Takeda UK Ltd
BNF chapter
Gastro-intestinal system
Submission type
Full
Status
Publication due date:
08 July 2019
SMC meeting date:
04 December 2018
Patient group submission deadline:
01 October 2018